0001231919-25-000372.txt : 20251030 0001231919-25-000372.hdr.sgml : 20251030 20251029175644 ACCESSION NUMBER: 0001231919-25-000372 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251030 DATE AS OF CHANGE: 20251029 EFFECTIVENESS DATE: 20251030 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Electra Therapeutics, Inc. CENTRAL INDEX KEY: 0002088082 ORGANIZATION NAME: EIN: 832193635 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-562489 FILM NUMBER: 251431398 BUSINESS ADDRESS: STREET 1: 230 EAST GRAND AVENUE, SUITE S-100 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (888) 743-2290 MAIL ADDRESS: STREET 1: 230 EAST GRAND AVENUE, SUITE S-100 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 D 1 primary_doc.xml X0708 D LIVE 0002088082 Electra Therapeutics, Inc. 230 EAST GRAND AVENUE, SUITE S-100 SOUTH SAN FRANCISCO CA CALIFORNIA 94080 (888) 743-2290 DELAWARE None None Corporation true Thomas Geninatti, Ph.D. C/O ELECTRA THERAPEUTICS, INC. 230 EAST GRAND AVENUE, SUITE S-100 SOUTH SAN FRANCISCO CA CALIFORNIA 94080 Director Beth Seidenberg, M.D. C/O ELECTRA THERAPEUTICS, INC. 230 EAST GRAND AVENUE, SUITE S-100 SOUTH SAN FRANCISCO CA CALIFORNIA 94080 Director Carl Gordon, Ph.D. C/O ELECTRA THERAPEUTICS, INC. 230 EAST GRAND AVENUE, SUITE S-100 SOUTH SAN FRANCISCO CA CALIFORNIA 94080 Director Matthew Fust C/O ELECTRA THERAPEUTICS, INC. 230 EAST GRAND AVENUE, SUITE S-100 SOUTH SAN FRANCISCO CA CALIFORNIA 94080 Director Nancy Stagliano, Ph.D. C/O ELECTRA THERAPEUTICS, INC. 230 EAST GRAND AVENUE, SUITE S-100 SOUTH SAN FRANCISCO CA CALIFORNIA 94080 Director Quehuong (Kathy) Dong, Pharm.D. C/O ELECTRA THERAPEUTICS, INC. 230 EAST GRAND AVENUE, SUITE S-100 SOUTH SAN FRANCISCO CA CALIFORNIA 94080 Executive Officer Director Biotechnology Decline to Disclose 06b false 2025-10-15 false true false 0 184133425 134188389 49945036 false 19 0 0 0 false Electra Therapeutics, Inc. /s/ Quehuong (Kathy) Dong Quehuong (Kathy) Dong, Pharm.D. President and CEO 2025-10-29